Skip to Content

Join the 'Diabetic Retinopathy' group to help and get support from people like you.

Diabetic Retinopathy News

Nearly 6 in 10 Diabetics Skip Eye Exams, Study Finds

Posted 10 Nov 2016 by Drugs.com

THURSDAY, Nov. 10, 2016 – Almost two-thirds of people with diabetes don't get annual eye exams, despite having an increased risk for serious eye disease and vision loss, researchers say. About one in 10 Americans has diabetes. Having a dilated eye exam yearly or more often can prevent 95 percent of diabetes-related vision loss, the study authors said. "Vision loss is tragic, especially when it is preventable," study lead author Dr. Ann Murchison said in a news release from the American Academy of Ophthalmology (AAO). "That's why we want to raise awareness and ensure people with diabetes understand the importance of regular eye exams," said Murchison. She is director of the eye emergency department at Wills Eye Hospital in Philadelphia. The study included information from nearly 2,000 people aged 40 and older with type 1 or type 2 diabetes. The researchers found that 58 percent didn't ... Read more

Related support groups: Diabetes, Type 2, Eye Conditions, Smoking, Smoking Cessation, Diabetes, Type 1, Insulin Resistance, Pre-Diabetes, Diabetes Mellitus, Retinal Disorders, Diabetic Retinopathy, Abnormal Glucose Tolerance, Visual Defect/Disturbance, Retinopathy

A Better Diabetes Test?

Posted 5 Oct 2016 by Drugs.com

WEDNESDAY, Oct. 5, 2016 – Industry-funded researchers say they've developed a way to improve the accuracy of a standard diabetes test. "We think our approach will enable many patients and their doctors to do a better job controlling blood sugar levels and reduce the long-term risks of heart attack, stroke, blindness and kidney failure" associated with diabetes, said Dr. John Higgins, associate professor of systems biology at Harvard Medical School in Boston. At issue is the HbA1c test, also known as the A1c test, which is used to diagnose diabetes. It also identifies people with prediabetes and provides insight into how well blood sugar is controlled over a three-month period among those monitoring their disease. The A1c test "measures how much sugar a person's blood cells have soaked up since the time the cells were produced," Higgins said. "Before the test was available, patients and ... Read more

Related support groups: Diabetes, Type 2, Diabetes, Type 1, Diabetic Neuropathy, Insulin Resistance, Diabetic Nerve Damage, Pre-Diabetes, Diabetes Mellitus, Diabetic Ketoacidosis (DKA), Diabetic Retinopathy, Diagnosis and Investigation, Abnormal Glucose Tolerance, Diabetic Ketoacidosis (in DM Type II), Diabetic Ketoacidosis (in DM Type I), Retinopathy Prophylaxis, Diabetic Coma (in DM Type I), Diabetic Coma, Diabetic Coma (in DM Type II)

When Diabetes Strikes, Get Moving to Lower Risk to Eyes

Posted 4 Aug 2016 by Drugs.com

THURSDAY, Aug. 4, 2016 – People with diabetes who remain inactive may have higher odds for a vision-robbing eye condition, new research suggests. While the study couldn't prove a cause-and-effect relationship, researchers say a "couch potato" lifestyle does seem to raise the risk for diabetic retinopathy. According to the U.S. National Eye Institute, the condition "involves changes to retinal blood vessels that can cause them to bleed or leak fluid, distorting vision." Diabetic retinopathy is the most common cause of vision loss for people with diabetes. Could exercise – or a lack of it – affect risk for the disease? To find out, a team led by Paul Loprinzi at the University of Mississippi tracked outcomes for 282 U.S. diabetes patients. The patients averaged 62 years of age. Nearly one-third (29 percent) had mild or more severe diabetic retinopathy. Using an accelerometer device to ... Read more

Related support groups: Diabetes, Type 2, Eye Conditions, Insulin Resistance, Pre-Diabetes, Diabetes Mellitus, Retinal Disorders, Diabetic Retinopathy, Abnormal Glucose Tolerance, Retinitis Pigmentosa, Visual Defect/Disturbance, Retinal Vasculitis, Retinal Hemorrhage, Retinopathy Prophylaxis

Tight Blood Sugar Control Helps Fight Diabetic Eye Disease

Posted 13 Jun 2016 by Drugs.com

SATURDAY, June 11, 2016 – Intensive blood sugar control appears to reduce the risk of eye disease progression in people with type 2 diabetes, a new study says. People with type 2 diabetes are at risk for the eye disease called diabetic retinopathy. This condition damages tiny blood vessels in the retina, the light-sensitive tissue in the back of the eye. Researchers compared type 2 diabetes patients who received either intensive therapy or standard therapy to control blood sugar. To measure how well the therapy worked, people in the study had hemoglobin A1C tests. The A1C test estimates several months of blood sugar levels. People are diagnosed with diabetes when their A1C is 6.5 percent or higher, the U.S. National Institute of Diabetes and Digestive and Kidney Disease says. In general, the goal for people with type 2 diabetes is to have an A1C of less than 7 percent, according to the ... Read more

Related support groups: Diabetes, Type 2, Eye Conditions, Diabetes, Type 1, Insulin Resistance, Pre-Diabetes, Diabetes Mellitus, Diabetic Retinopathy, Abnormal Glucose Tolerance, Retinopathy Prophylaxis

Cost of Insulin Rises Threefold in Just a Decade: Study

Posted 5 Apr 2016 by Drugs.com

TUESDAY, April 5, 2016 – Americans with diabetes who rely on insulin to keep their blood sugar levels in check are facing sticker shock: A new study finds the price of insulin has tripled in only 10 years. Moreover, since 2010, per-person spending on insulin in the United States was more than spending on all other diabetes drugs, the study found. "The cost of insulin has risen rapidly over the last few years," said study senior author Philip Clarke, a professor of health economics at the University of Melbourne in Australia. Clarke added there should be an assessment to see whether this price hike is justifiable in terms of improved clinical outcomes. One reason for the price climb, he said, is a switch from human insulins to analog insulins, which cost more but may offer additional benefits. Also, doctors are more apt to prescribe insulin for people with type 2 diabetes now, Clarke ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Lantus, Diabetes, Type 1, Januvia, Glucophage, Novolog, Diabetic Neuropathy, Glipizide, Humalog, Insulin Resistance, Janumet, Diabetic Nerve Damage, Byetta, Saxenda, Glyburide, Bydureon, Lantus Solostar

New Transplant Technique Might Free Type 1 Diabetics From Daily Injections

Posted 27 Jan 2016 by Drugs.com

WEDNESDAY, Jan. 27, 2016 – Using a two-pronged approach, researchers report they were able to restore normal blood sugar levels for six months in mice with induced diabetes. But, while the research is promising, it's too soon for people with type 1 diabetes to start planning a life free of needles and injections just yet, experts said. The first part of the treatment was using insulin-producing pancreas cells generated from human stem cells employing a technique recently developed at Harvard. But the latest breakthrough came from MIT researchers, who developed a way to encapsulate the cells – called islet cells – before they were implanted in the mice, to protect them from the immune system. That's key for two reasons. One is that when you introduce foreign cells into the body, the immune system recognizes them as foreign and destroys them. This is why people who have organ ... Read more

Related support groups: Diabetes, Type 1, Diabetic Neuropathy, Insulin Resistance, Diabetic Nerve Damage, Pre-Diabetes, Diabetes Mellitus, Organ Transplant, Diabetic Ketoacidosis (DKA), Diabetic Retinopathy, Abnormal Glucose Tolerance, Intravenous Insulin Drip, Diabetic Coma

Nasal Spray May Give Diabetics Faster Treatment for Low Blood Sugar

Posted 18 Dec 2015 by Drugs.com

FRIDAY, Dec. 18, 2015 – A new nasal spray might make rescue care easier for diabetics who are woozy or even unconscious due to severe low blood sugar, a new clinical trial suggests. The nasal spray contains powdered glucagon, a hormone that causes a prompt increase in blood sugar levels. The trial results showed that the nasal spray is nearly as effective in treating hypoglycemia (low blood sugar) as the only option currently available, a glucagon powder that must be mixed with water, drawn into a syringe and then injected into muscle. Because it is almost as effective but much easier to administer to an ailing person, the nasal spray could become the go-to treatment for severe hypoglycemia, said Dr. George Grunberger, a clinical professor at Wayne State University School of Medicine in Detroit and president of the American Association of Clinical Endocrinologists. He was not involved ... Read more

Related support groups: Diabetes, Type 2, Diabetes, Type 1, Diabetic Neuropathy, Hypoglycemia, Insulin Resistance, Diabetic Nerve Damage, Pre-Diabetes, Diabetes Insipidus, Diabetes Mellitus, Diabetic Ketoacidosis (DKA), Diabetic Retinopathy, Abnormal Glucose Tolerance, Glucagon, Diabetic Ketoacidosis (in DM Type II), GlucaGen, Diabetic Ketoacidosis (in DM Type I), Intravenous Insulin Drip, Diabetic Coma (in DM Type I), Diabetic Coma, Diabetic Coma (in DM Type II)

Drug Lucentis May Fight Diabetic Eye Disease

Posted 13 Nov 2015 by Drugs.com

FRIDAY, Nov. 13, 2015 – The injected drug Lucentis (ranibizumab) appears highly effective at treating proliferative diabetic retinopathy, a common diabetes-related eye disease, new research shows. Investigators say the drug beat a standard treatment, laser therapy, in curbing the vision-robbing ailment. The findings, "provide crucial evidence for a safe and effective alternative to laser therapy against proliferative diabetic retinopathy," NEI Director Dr. Paul Sieving said in a news release from the U.S. National Eye Institute (NEI). The study was funded by the NEI, which described Lucentis as the first major advance in therapy for proliferative diabetic retinopathy in nearly 40 years. The trial was conducted by the Diabetic Retinopathy Clinical Research Network. The results were published online Nov. 13 in the Journal of the American Medical Association and they are also slated for ... Read more

Related support groups: Lucentis, Diabetic Retinopathy, Retinopathy Prophylaxis, Ranibizumab

Can Eye Screening for Diabetic Kids Be Delayed a Bit?

Posted 9 Sep 2015 by Drugs.com

WEDNESDAY, Sept. 9, 2015 – Children with type 1 diabetes may not need to start screening for eye disease as early as currently recommended, a new study suggests. Most children with type 1 diabetes probably don't need a yearly exam for diabetes-related eye disease (diabetic retinopathy) until age 15, or 5 years after their diabetes diagnosis, whichever is later, the study authors reported online Sept. 1 in the journal Ophthalmology. "Many of our young patients with diabetes diligently come in every year for screenings that consistently show no sign of the disease," study co-author Dr. Gil Binenbaum, attending surgeon in the ophthalmology division at The Children's Hospital of Philadelphia, said in a journal news release. "Of course, that's good news for them, and it is very important to have annual eye exams once the risk of vision loss develops. But, is it worth the burden on the ... Read more

Related support groups: Diabetes, Type 1, Diabetic Retinopathy, Diagnosis and Investigation

Health Tip: Diabetes Can Take a Toll on Teeth and Mouth

Posted 10 Aug 2015 by Drugs.com

-- Diabetes, especially when uncontrolled, can cause damage to your mouth and teeth. The Mouthhealthy.org website says possible effects of diabetes on the teeth and mouth include: Dry mouth, due to decreased saliva production. Increased risk of cavities due to less saliva. Gingivitis, characterized by bleeding, inflamed gums. Difficulty tasting food. Slower healing of mouth wounds. Increased risk of infection. Among diabetic children. teeth emerging earlier than expected. Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Oral and Dental Conditions, Xerostomia, Lantus, Toothache, Diabetes, Type 1, Januvia, Glucophage, Novolog, Burning Mouth Syndrome, Diabetic Neuropathy, Glipizide, Humalog, Insulin Resistance, Janumet, Diabetic Nerve Damage, Aphthous Ulcer

Uncontrolled Diabetes May Boost Dementia Risk

Posted 9 Jul 2015 by Drugs.com

THURSDAY, July 9, 2015 – Diabetes patients with high rates of complications from the disease may face increased risk for dementia, a new study suggests. "We found that as diabetes progresses and an individual experiences more complications from the disease, the risk of dementia rises as well," wrote Dr. Wei-Che Chiu, of the National Taiwan University College of Public Health, in Taipei. Better blood sugar control can help prevent the mental decline associated with diabetes, he and his colleagues said. They examined data from more than 431,000 people in Taiwan who were older than 50 and newly diagnosed with diabetes. Complications of diabetes include vision loss, kidney failure and nerve damage. Over 12 years of follow-up, more than 6 percent of the patients were diagnosed with dementia. Those with a greater number of diabetes complications were at higher risk for mental decline than ... Read more

Related support groups: Diabetes, Type 2, Peripheral Neuropathy, Dementia, Diabetes, Type 1, Alzheimer's Disease, Diabetic Neuropathy, Diabetic Nerve Damage, Pre-Diabetes, Diabetic Kidney Disease, Mild Cognitive Impairment, Diabetes Mellitus, Diabetic Nephropathy, Arteriosclerotic Dementia, Diabetic Retinopathy, Abnormal Glucose Tolerance, Lewy Body Dementia, Retinopathy Prophylaxis

Sleep Apnea Treatment May Help Lower Diabetes Risk for Some

Posted 6 May 2015 by Drugs.com

TUESDAY, May 5, 2015 – Treating sleep apnea may help people with slightly elevated blood sugar levels lower their risk of developing diabetes, according to a new study. "Assessment of sleep apnea should be considered in patients at high risk for diabetes and cardiovascular disease, since our study shows that treatment of sleep apnea can reduce these risks," the study's senior author, Dr. Esra Tasali, an assistant professor of medicine at the University of Chicago, said in a university news release. People with higher-than-normal blood sugar levels who don't yet have diabetes are considered to have pre-diabetes. This condition affects about 57 million Americans, according to the researchers. Many people with pre-diabetes also have untreated sleep apnea – a sleep disorder that causes the upper airway to close repeatedly during the night, disrupting sleep and temporarily reducing oxygen ... Read more

Related support groups: Diabetes, Type 2, Obesity, Diabetic Neuropathy, Insulin Resistance, Diabetic Nerve Damage, Sleep Apnea, Pre-Diabetes, Diabetes Mellitus, Cardiovascular Risk Reduction, Obstructive Sleep Apnea/Hypopnea Syndrome, Diabetic Retinopathy, Abnormal Glucose Tolerance, Retinopathy Prophylaxis

Better Diabetes Blood Sugar Management Leads to Fewer Eye Surgeries

Posted 29 Apr 2015 by Drugs.com

WEDNESDAY, April 29, 2015 – Intensive management of type 1 diabetes can reduce the risk of having a diabetes-related eye surgery by nearly 50 percent, according to a new report. But even for people who couldn't meet the very stringent blood sugar targets set for the study participants, just a 10 percent improvement in hemoglobin A1C – a two- to three-month estimate of average blood sugar levels – led to a 35 percent reduction in the risk of diabetes-related eye surgery, the study found. "We're showing how a modest period of tight blood sugar control can lower the need for eye surgery, even way downstream," said the study's senior author, Dr. David Nathan, director of the Massachusetts General Hospital Diabetes Center and Clinical Research Center in Boston. In general, the A1C goal for people with type 1 diabetes – an autoimmune disease that destroys the body's ability to produce the ... Read more

Related support groups: Insulin, Lantus, Diabetes, Type 1, Novolog, Humalog, Cataract, Lantus Solostar, Levemir, Novolin R, Novolin N, Lantus Solostar Pen, Humulin N, Humulin R, NovoLog FlexPen, Humalog KwikPen, Apidra, Toujeo, Insulin Glargine, Humalog Pen, Humalog Mix 75/25

FDA OKs New Drug for Diabetes-Linked Eye Condition

Posted 26 Mar 2015 by Drugs.com

WEDNESDAY, March 25, 2015 – The U.S. Food and Drug Administration on Wednesday approved the use of Eylea, an injected drug, to treat diabetic retinopathy in patients with diabetic macular edema. According to the U.S. Centers for Disease Control and Prevention, diabetic retinopathy is a leading cause of blindness in American adults. A third of those over 40 with diabetes have some form of the eye condition, according to 2008 data, the CDC said. Overall, more than 29 million people in the United States have type 1 or type 2 diabetes, and diabetes remains the leading cause of new blindness among people aged 20 to 74, the CDC noted. In some people who have diabetic retinopathy with macular edema, abnormal new blood vessels grow on the surface of the retina. If those new blood vessels break, severe vision loss or blindness can occur. "The major cause of vision loss occurs when abnormal ... Read more

Related support groups: Eylea, Diabetic Retinopathy

Eylea Approval Expanded to Include Diabetic Retinopathy

Posted 26 Mar 2015 by Drugs.com

WEDNESDAY, March 25, 2015 – U.S. Food and Drug Administration approval of Eylea (aflibercept) has been expanded to treat diabetic retinopathy among people with diabetic macular edema, the agency said Wednesday in a news release. Affecting more than 29 million people in the U.S., diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness, the FDA said. Among some people who have vision-impairing diabetic macular edema, diabetic retinopathy can spur the growth of abnormal blood vessels on the eye's retina. If these vessels burst, it can lead to severe vision loss or blindness. The injected drug Eylea is intended to be used in tandem with appropriate therapies to control blood sugar, blood pressure and cholesterol, the FDA said. The drug's safety and effectiveness were evaluated in clinical studies involving nearly 680 people. The most common side ... Read more

Related support groups: Eylea, Diabetic Retinopathy, Aflibercept

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Retinopathy Prophylaxis, Diabetes Mellitus

Related Drug Support Groups

Lucentis, Eylea, aflibercept, ranibizumab